The use of yellow fever virus modified by in vitro cultivation for human immunization. J. Exp. Med. 65, 787-800 (1937)
Theiler
M
M
Laboratories of the International Health Division, The Rockefeller Foundation, New York, USA.
Smith
H H
HH
D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D049673:History, 20th Century; D006801:Humans; D008253:Macaca mulatta; D014611:Vaccination / Q000266:history; D014613:Vaccines, Attenuated / Q000266:history / Q000276:immunology; D014765:Viral Vaccines / Q000266:history* / Q000276:immunology; D014776:Virus Cultivation / Q000266:history; D015004:Yellow Fever / Q000266:history* / Q000517:prevention & control; D015005:Yellow fever virus / Q000472:pathogenicity / Q000502:physiology*
D000914:Antibodies, Viral; D014613:Vaccines, Attenuated; D014765:Viral Vaccines